DMD, BMD: Trial of Ataluren in Nonwalkers

PTC Therapeutics, with support from MDA, is testing ataluren in boys with DMD or BMD who have nonsense mutations and are no longer walking.
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.